EyewireTV — Stem Cell Breakthrough, Lucentis China Approval, Dry Eye Treatments
In this week's EyewireTV, human embryonic stem cells for the first time are safely used to treat macular degeneration in two patients, and Novartis receives regulatory approval in China for Lucentis as a treatment for wet AMD. In the weekly feature, cataract surgeons share their thoughts on why there is an increased focus on dry eye disease, and how it is impacting the marketplace for dry eye treatment.
posted Wednesday, January 25, 2012 | 2,860 views
Related Videos
5/22/2013 | 879 views
EyewireTV — Trulign Toric IOL Approval, Infant Laser Cataract Surgery, Toric IOL Growth
In this week's EyewireTV, the Trulign Toric posterior chamber IOL (Bausch + Lomb), the first IOL to provide both astigmatic correction and improved uncorrected near, intermediate, and distance vision, receives FDA approval; and the first four reported cases of femtosecond laser cataract surgery in infants demonstrate that the procedure has great potential for making challenging surgeries easier and more predictable. In the weekly feature, two leading ophthalmic surgeons discuss the growing toric IOL segment and how the growth is benefiting both patients and physicians. Watch Video
5/15/2013 | 940 views
EyewireTV — LASIK Satisfaction Survey, Donor Tissue Corneal Transplant, HD Analyzer Launch
In this week's EyewireTV, a large survey shows patients’ satisfaction with LASIK is high, but misconceptions and fears about the procedure persist; and the first corneal transplants using preloaded donor tissue are performed at Massachusetts Eye and Ear Infirmary. In the weekly feature, two leaders in refractive surgery discuss the most effective methods to market LASIK to Generation Y patients. Watch Video
5/8/2013 | 1,495 views
EyewireTV — AREDS 2 Study Results; AMD Drug Delay; Incise Microincision IOL Launch
In this week's EyewireTV, a major government-sponsored study reveals that omega-3 fatty acids and carotenoids do not further reduce the risk of progression to advanced AMD; and Allergan, Inc., announces it will not advance its major drug candidate Darpin into late-stage trials this year, delaying the possible release of the AMD drug by 1 to 2 years. Also, Bausch + Lomb launches its Incise Microincision IOL in Europe. The lens allows surgeons to perform sub–2-mm microincision cataract surgery. Watch Video
5/1/2013 | 939 views
EyewireTV — Simbrinza Approval, Ophthalmologists' Compensation, Glaucoma Pipeline
In this week's EyewireTV, the FDA approves Alcon’s Simbrinza suspension, indicated for the reduction of elevated IOP in patients with primary open-angle glaucoma or ocular hypertension; and a new report reveals that ophthalmologists’ compensation on average grew 5% between 2011 and 2012, reflecting a relatively stable overall financial picture. In the weekly feature, two leading glaucoma specialists discuss some of the exciting innovations in the treatment of glaucoma, including combination therapies and drug delivery options. Watch Video
4/24/2013 | 1,334 views
EyewireTV — Ziemer Z6 Bladeless Cataract Module, New Zeiss OR Management System, ORA Upgrade
In this week's special edition of EyewireTV, the most significant industry announcements from the annual cataract and refractive surgery meeting in San Francisco are reported live from the showroom floor. Ziemer Ophthalmic Systems AG announces a new software module for its Femto LDV Z6 that will allow surgeons to perform bladeless cataract surgery; and Carl Zeiss Meditec AG introduces the Callisto eye OR management system to assist cataract surgeons in the precise alignment of IOLs. Also, WaveTec Vision launches VerifEye, a new monitoring system for the ORA that provides surgeons continuous refractive information. Watch Video
4/16/2013 | 1,391 views
EyewireTV — Trulign IOL Recommendation, New Femto User Survey, Jetrea UK Launch
In this week's EyewireTV, Bausch + Lomb’s Trulign toric accommoding IOL receives a key recommendation from an FDA advisory panel; and a new, wide-reaching user survey shows that femtosecond lasers are expanding the premium channel in cataract surgery. Also, Jetrea (ocriplasmin) is launched in the United Kingdom for the treatment of vitroemacular traction. Watch Video
4/10/2013 | 1,225 views
EyewireTV — Prolensa Approval, Femto Platform Advancements, New Femtosecond Instruments Set
In this week's EyewireTV, the FDA approves Bausch + Lomb’s new drug application for Prolensa, a once-daily NSAID for the treatment of inflammation and reduction of pain after cataract surgery; the Lensar Laser System receives FDA 510(k) clearance for the execution of arcuate incisions during cataract surgery; and the Victus Femtosecond Laser Platform receives the CE mark for the creation of corneal incisions in patients undergoing cataract surgery. Watch Video
4/3/2013 | 1,270 views
EyewireTV — BromSite Phase 3 Results, B+L IPO Filing, Laser Cataract Surgery Finances
In this week's EyewireTV, InSite Vision Inc. announces top-line results from its recently completed phase 3 clinical trial of BromSite for the reduction of inflammation and pain after cataract surgery; and Bausch + Lomb files a registration statement with the US Securities and Exchange Commission to allow for a proposed initial public offering. In the weekly feature, two early adopters of laser cataract surgery discuss the financial model they employ in their practices and the conversation they have with patients when explaining the new technology. Watch Video
3/27/2013 | 1,067 views
EyewireTV — SARcode Bioscience Sold, Kamra Inlay PMA Application, Vitra Multispot Laser Clearance
In this week's EyewireTV, SARcode Bioscience Inc., the maker drug candidate lifitegrast for the treatment of dry eye, is acquired by Shire US Holdings Inc.; and AcuFocus submits the final module of their premarket approval application to the FDA for the Kamra corneal inlay. Also, Quantel Medical receives FDA 510(k) clearance for its Vitra Multispot laser; and Optos receives FDA 510(k) clearance for microperimetry as part of the Optos OCT SLO. Watch Video
3/20/2013 | 1,128 views
EyewireTV — European Jetrea Approval, Vision Loss-Depression Link, LASIK Xtra Training
In this week’s EyewireTV, Jetrea receives another major approval for the treatment of vitreomacular traction, and a large survey reveals adults with self-reported visual function loss are twice as likely to be depressed as other adults. In the weekly feature, retina specialists discuss which future therapeutic approaches or surgical techniques they anticipate will improve the treatment of vitreoretinal diseases. Watch Video
3/13/2013 | 1,342 views
EyewireTV — Avellino Corneal Dystrophy Test, Healon Dual Pack OVD Launch, Retina Advancements
In this week's EyewireTV, a new company offers the first genetic test for Avellino Corneal Dystrophy in the United States, and Abbott launches the Healon Duet Dual Pack OVD for use in cataract extraction and IOL implantation. In the weekly feature, four leading retina specialists discuss which recent approvals or milestone clinical trial results will have a significant impact on their practice. Watch Video
3/6/2013 | 1,206 views
EyewireTV — Glaucoma Micro-Stent Study, AMD Genes Discovered, New B+L President
In this week's EyewireTV, enrollment is completed in a key study evaluating the CyPass Micro-Stent in combination with cataract surgery for patients with primary open-angle glaucoma; and an international group of researchers discover seven new regions of the human genome associated with increased risk of AMD. In the weekly feature, experts discuss how ongoing changes in health care are challenging physicians to reevaluate their practices in order to function more efficiently. Watch Video
2/27/2013 | 1,311 views
EyewireTV — Laser Cataract Surgery Patent, New Glaucoma Drug, Inlay Trial
In this week's EyewireTV, the U.S. Patent & Trademark Office grants OptiMedica Corp. a patent relating to the fundamental technology underlying laser cataract surgery; and Rescula 0.15%, a treatment for lowering IOP in patients with open-angle glaucoma or ocular hypertension, is now available in the United States. In the weekly feature, two leading ophthalmologists sit down with EyewireTV at the ACOS-Dulaney Winter Meeting in Aspen to discuss how new treatments available for postoperative pain and inflammation affect their therapeutic decisions. Watch Video
2/20/2013 | 1,500 views
EyewireTV - Argus II FDA Approval, Victus Incisions Clearance, New Fundus Camera
In this week's EyewireTV, the Argus II Retinal Prosthesis System, a device that restores some functional vision to blind people with late-stage retinitis pigmentosa, receives FDA approval; and the Victus Femtosecond Laser Platform receives 510(k) clearance from the FDA for the creation of penetrating arcuate cuts and corneal incisions during cataract surgery. In the weekly feature, EyewireTV News Director Stephen Daily interviews Second Sight Chief Executive Robert Greenberg, MD, PhD, who discusses the technology and unique capabilities of the Argus II Retinal Prosthesis System. Watch Video
2/13/2013 | 1,317 views
EyewireTV — Cataract Surgery After LASIK, C-Reactive Protein-AMD Link, OCT Database Clearance
In this week's EyewireTV, a new study reveals a molecule linked to cardiovascular disease may also be associated with an increased risk of developing AMD; and Optovue receives 510(k) clearance from the FDA for the iVue SD-OCT Normative Database. In the weekly feature, experts discuss the unique challenges of performing cataract surgery on patients who have had previous refractive surgery. Watch Video
2/6/2013 | 2,015 views
EyewireTV — CMS Sunshine Act Ruling, Posterior Microinjection Platform, Infiniti Vision System Upgrade
In this week's EyewireTV, CMS announces a final rule on the Sunshine Act that will change the way physicians and manufacturers report financial relationships; and new technology that delivers drugs for retinal diseases via the suprachoroidal space gets major financial backing. Also, Alcon launches hardware and software upgrades for its Infiniti Vision System that it says will provide surgeons greater control during cataract surgery. Watch Video
1/30/2013 | 1,466 views
EyewireTV — Lotemax Gel Launch, Aspirin-AMD Link, Medicaid Patient Increase
In this week’s EyewireTV, Lotemax gel (loteprednol etabonate 0.5%), indicated to treat inflammation and pain following ocular surgery, is now available in pharmacies nationwide; and a new study provides more evidence that long-term use of aspirin is associated with an increased risk of wet AMD. In the weekly feature, two leading surgeons discuss how health care reform is expected to increase the number of Medicaid patients and what ophthalmologists should do to prepare for this change. Watch Video
1/23/2013 | 1,703 views
EyewireTV - Ilevro NSAID Launch, LipiView Upgrade, EyewireTV 2.0
In this week's EyewireTV, Alcon announces the launch of Ilevro, a new once-daily NSAID for the treatment of pain and inflammation associated with cataract surgery; and the FDA clears additional features and broadens the indication of TearScience's LipiView Ocular Surface Interferometer. Also, Bryn Mawr Communications LLC announces the launch of EyewireTV 2.0, a redesign of the weekly news broadcast featuring a new set, interactive news content, and more on-location interviews. Watch Video
1/16/2013 | 3,294 views
EyewireTV - First Patients Treated with Jetrea; Hyperemia Treatment; Haag-Streit Partnership
In this week's EyewireTV, Allen Ho, MD, a retina specialist at the Wills Eye Hospital in Philadelphia, treats the first patient in the United States with Jetrea (ocriplasmin), which was recently approved by the FDA for the treatment of symptomatic VMA; and Bausch + Lomb acquires the global licensing rights to a new platform technology that may lead to a faster, more effective treatment for hyperemia. Watch Video
1/9/2013 | 1,332 views
EyewireTV — Glaucoma Increase, Non-Contact Tonometer Clearance, Marketing Advice
In this week's EyewireTV, a new report from Prevent Blindness America and the National Eye Institute shows the prevalence of open-angle glaucoma has increased more than 20% in the last 10 years; and Oculus receives FDA clearance for the Corvis ST noncontact tonometer. In the weekly feature, two leading ophthalmologists discuss when it is appropriate to hire a professional outside marketer and how members of your own staff can increase customer satisfaction. Watch Video
1/2/2013 | 1,941 views
EyewireTV — 2012 Year in Review
In this week's EyewireTV, we take a look back at the most significant stories of 2012, including major advancements in the treatment of blinding retinal diseases, the first-ever ab interno glaucoma implant to be approved in the United States, and the commercialization of femtosecond lasers for use in cataract surgery. Watch Video
12/19/2012 | 1,239 views
EyewireTV — Visual Impairment/Diabetes Study, B+L Sale Reports, Rescula sNDA Approval
In this week's EyewireTV, a new study shows the prevalence of nonrefractive visual impairment has increased in recent years due in large part to a higher prevalence of diabetes; and Warburg Pincus LLC has reportedly hired Goldman Sachs to explore the option of selling Bausch + Lomb. Watch Video
12/12/2012 | 1,419 views
EyewireTV — Lensar Corneal Incisions Clearance, TxCell Laser Delivery Clearance, Integrated Care
In this week's EyewireTV, the Lensar Laser System receives 510(k) clearance from the FDA for performing corneal incisions during cataract surgery; and Iridex Corp. receives FDA 510(k) clearance and CE Mark approval of the TxCell Scanning Laser Delivery System. In the weekly feature, ophthalmologists share their thoughts on the need for more practices to adopt an integrated approach to eye care. Watch Video
12/5/2012 | 1,376 views
EyewireTV — Election Impact, BromSite Trial, Iluvien Setback
In this week’s EyewireTV, InSite Vision Inc. announces that patient enrollment has been completed in the first phase 3 clinical trial of BromSite for the reduction of pain and inflammation after cataract surgery; and Lenstec, Inc. launches the Softec HD Oval IOL in the United States, the first FDA-approved oval, one-piece foldable IOL. In the weekly feature, leading ophthalmologists discuss the impact that the recent elections may have on reimbursement and patient care. Watch Video
11/28/2012 | 1,528 views
EyewireTV — CMS Femto Billing Guidance, Elyea AMD European Approval, Alcon Acquisition
In this week's EyewireTV, the Centers for Medicare & Medicaid Services issues guidance that clarifies how physicians may charge when using a femtosecond laser for cataract surgery; Eylea (aflibercept) is approved in Europe for the treatment of wet AMD; and Alcon acquires the ophthalmic division of SensoMotoric Instruments GmbH, a manufacturer of computer vision applications. Watch Video
11/14/2012 | 2,131 views
EyewireTV — Live Coverage of the AAO Annual Meeting in Chicago
In this week's EyewireTV, Alcon introduces the SoftFit patient interface for the LenSx Laser platform; Carl Zeiss Meditec introduces several new Cirrus OCT models, including the Cirrus HD-OCT 5000; and Topcon Medical Systems, Inc., reveals several new products, including a posterior imaging system and a pattern scanning retinal laser. Watch Video
11/7/2012 | 1,905 views
EyewireTV — Abbott Split, Laser Cataract Surgery Tools, Avedro CXL Patents
In this week's EyewireTV, Abbott Laboratories sells $14.7 billion worth of bonds in the largest dollar-denominated offering in more than three years as the drug and medical-device maker prepares to split in two; and Accutome introduces three surgical tools to aid femtosecond laser-assisted cataract surgery. In the weekly feature, surgeons who own the Wavetec ORA system explain why they believe it has been a worthwhile investment for the practice. Watch Video
10/24/2012 | 2,070 views
EyewireTV — Ocriplasmin FDA Approval, Lifitegrast Dry Eye Study, Malpractice Exposure
In this week's EyewireTV, the FDA approves ocriplasmin (Jetrea, ThromboGenics NV) for the treatment of symptomatic vitreomacular adhesion; and SARcode Bioscience Inc. announces the results of a pivotal phase 3 study of its drug candidate lifitegrast for the treatment of dry eye disease. In the weekly feature, ophthalmologists talk about the importance of patient communication and offer their advice for physicians to reduce their malpractice exposure. Watch Video
10/17/2012 | 1,883 views
EyewireTV — Smoking-Cataract Study, Keraflex Microwave Treatment, Laser Cataract Surgery Experience
In this week's EyewireTV, a new study shows evidence that smoking may increase the risk of age-related cataract; and the first patients are treated in an investigational new drug study examining the safety and efficacy of the Keraflex Microwave System for the treatment of keratoconus. In the weekly feature, a leading ophthalmologist and a director of a major eye care center discuss their early experience with laser cataract surgery. Watch Video
10/10/2012 | 1,495 views
EyewireTV – New LenSx Laser Clearance, Lucentis DME Recommendation, Glaucoma-Coffee Link
In this week's EyewireTV, Alcon’s LenSx Laser System is cleared by the FDA for corneal flap creation in refractive surgical procedures; and NICE recommends Lucentis as an option for treating visual impairment caused by DME. In the weekly feature, leading European ophthalmologists explain how new technology, such as intraoperative aberrometry, is helping physicians determine IOL power after refractive surgery. Watch Video
10/3/2012 | 1,783 views
EyewireTV — B+L-Cirle Partnership, Retinal Prosthesis Advancement, Women Ophthalmologists
In this week's EyewireTV, a new partnership between Bausch + Lomb and medical incubator Cirle Inc. aims to advance early-stage technologies and develop treatments for unmet ocular conditions; and an FDA advisory committee recommends approval of the Argus II Retinal Prosthesis System, an artificial retina device for patients with retinitis pigmentosa. In the weekly feature, EyewireTV speaks with four leading female ophthalmologists who share their advice for women who are considering a career in ophthalmology. Watch Video
9/26/2012 | 1,606 views
EyewireTV — New Eylea Approval, Visudyne Sale, Besivance Indications
In this week's EyewireTV, the FDA approves Eylea (aflibercept) for the treatment of macular edema following central retinal vein occlusion; and QLT Inc. sells its Visudyne business to Valeant Pharmaceuticals International Inc. for $112.5 million dollars plus contingency payments. In the weekly feature, leading ophthalmologists discuss the pros and cons of performing same-day bilaterial intraocular surgery. Watch Video
9/19/2012 | 1,617 views
EyewireTV — Alzheimer – Cataract Link, New Premium IOLs, Postop Car Accidents
In this week’s EyewireTV, investigators at Boston University Schools of Medicine and Public Health identify a gene linking age-related cataracts and Alzheimer disease; and Abbott Medical Optics Inc. and Bausch + Lomb announce the approval and release of premium IOL models in Europe. In the weekly feature, eye care practitioners discuss the importance of communicating to patients the benefits of vitamins and nutrition in supporting ocular health. Watch Video
9/12/2012 | 1,906 views
EyewireTV — ESCRS Meeting Coverage, LensAR Laser CE Mark, DORC Phaco System Launch
In this week's EyewireTV, LensAR Inc. receives CE Mark approval to market its LensAR Laser System in Europe; and DORC International announces the release of the EVA VacuFlow VTI for vitreoretinal and cataract surgery. In the weekly feature, leading European surgeons talk about the ophthalmic technology they are most excited about that is available in Europe but not the United States, and the potential advantages and disadvantages of having earlier access to technology. Watch Video
9/5/2012 | 1,379 views
EyewireTV — Catalys Corneal Incision Clearance, LASIK Adhesion, Cystic Fibrosis Pill-Cataract Link
In this week's EyewireTV, the FDA grants 510(k) clearance to OptiMedica Corp. for its Catalys Precision Laser System to create corneal incisions; and Kansas State University researchers develop a glue mixture that may reduce the risk of complications after laser vision correction surgery. In the weekly feature, ophthalmologists share what they believe are the top three elements to achieve success for patients undergoing cataract surgery. Watch Video
8/29/2012 | 1,685 views
EyewireTV — Biological Drugs Agreement, Diagnostic Code Delay, Retinal Research Grants
In this week's EyewireTV, Allergan, Inc., enters into two agreements with Molecular Partners AG to develop and commercialize a class of biological drugs for the treatment of ophthalmic diseases; and the US Department of Health and Human Services pushes back the implementation of a new and controversial set of diagnostic codes called ICD-10 to October 1, 2014. In the weekly feature, leading refractive surgeons share pearls on what to look for when screening patients for refractive surgery and the importance of corneal topography. Watch Video
8/22/2012 | 1,723 views
EyewireTV — Charges Filed by the US Securities and Exchange Commission, Ocriplasmin NEJM Study, IOP-Monitoring Contacts
In this week's EyewireTV, Jim Mazzo, president of Abbott Medical Optics Inc., was charged by the US Securities and Exchange Commission with violations of federal securities laws for allegedly tipping material nonpublic information about the proposed acquisition of AMO by Abbott Laboratories before the public announcement of the transaction in January 2009; and a study shows that a single intravitreal injection of ocriplasmin resulted in a statistically significant improvement in vitreomacular traction and macular holes. Watch Video
8/15/2012 | 1,751 views
EyewireTV — Lucentis DME Approval, Statin-Cataract Link, Medicaid Acceptance
In this week's EyewireTV, the FDA approves Lucentis (ranibizumab) for the treatment of diabetic macular edema, and a new study finds that diabetic patients taking cholesterol-lowering statins might have an increased risk of developing age-related cataracts. In the weekly feature, ophthalmologists discuss the best ways to preoperatively manage patients who have coexisting ocular inflammatory disease. Watch Video
8/8/2012 | 1,655 views
EyewireTV — Victus Clearance, Iluvien FDA Submission, Cataract/Hip Fracture Study
In this week's EyewireTV, Bausch + Lomb and Technolas Perfect Vision announce that the Victus Femtosecond Laser Platform has received 510(k) clearance from the FDA, and Alimera Sciences intends to resubmit its US application to the FDA for Iluvien for the treatment of diabetic macular edema. In the weekly feature, EyewireTV News Director Stephen Daily Skypes with Bausch + Lomb Chief Medical Officer Cal Roberts, MD, about the capabilities of the Victus femtosecond laser platform following its FDA clearance. Watch Video
8/1/2012 | 2,151 views
EyewireTV — ACOS CXL Trial Begins, Lucentis DME Recommendation, Ocriplasmin VMA Recommendation
In this week's EyewireTV, the American-European Congress of Ophthalmic Surgery (ACOS) and Avedro Inc. jointly announce that the first patients have been treated in the ACOS accelerated cross-linking study; and an FDA advisory committee votes unanimously to recommend approval of Lucentis for the treatment of diabetic macular edema. In the weekly feature, leading ophthalmologists at the ACOS Summer Symposium in Park City, Utah, discuss the Affordable Care Act and the impact it could have on their practice and patients. Watch Video
7/25/2012 | 2,018 views
EyewireTV — Microneedles AMD Study, Alcon Acquires Endure Medical, VEGF Stroke Study
In this week’s EyewireTV, new research indicates that tiny microneedles may be a safer and more effective way to treat AMD and other posterior segment eye diseases; and Alcon acquires Endure Medical Systems, a company specializing in advanced technology surgical microscopes. In the weekly feature, experts discuss the impact that emerging femtosecond laser technology will have on the adoption of premium IOLs. Watch Video
7/18/2012 | 2,008 views
EyewireTV — Eyesight Barometer Study, iPhone Imaging Tool, Femtosecond Investment
In this week’s EyewireTV, a new study reveals that almost 70% of people would rather give up 10 years of their life than lose their eyesight; and the Apple iPhone may be a reliable tool for ophthalmologists to remotely view medical images and assess patients when a standard workstation is not available, a new study suggests. In the weekly feature, ophthalmologists discuss what data they would like to see before investing in femtosecond laser technology for cataract surgery. Watch Video
7/11/2012 | 1,858 views
EyewireTV — Healon EndoCoat OVD Approval, VersaVit Clearance, Stroke Detection
In this week's EyewireTV, Abbott Medical Optics Inc. receives FDA approval for Healon EndoCoat OVD for use in cataract surgery; and Synergetics USA receives 510(k) clearance from the FDA for its VersaVit vitrectomy system. In the weekly feature, opinion leaders discuss what factors should be taken into account when deciding whether to prescribe generic or branded medications. Watch Video
6/27/2012 | 2,502 views
EyewireTV — Glaukos iStent FDA Approval, New Hydrophobic IOL, Vision Impairment Study
In this week’s EyewireTV, Glaukos Corp. receives FDA approval for the iStent Trabecular Micro-Bypass, the first-ever ab interno glaucoma implant to be approved in the United States; and a new report released by the National Eye Institute shows a 23% increase in vision impairment and blindness since 2000 in individuals over 40. In the weekly feature, Eric Donnenfeld, MD, shares his experience implanting the iStent Micro-Bypass and talks about how microinvasive glaucoma surgery is effective in reducing reliance on glaucoma medications. Watch Video
6/20/2012 | 2,035 views
EyewireTV — LensAR Clearance, New CXL Formulations, Dry Eye Tools
In this week’s EyewireTV, the LensAR Laser System receives 510(k) clearance from the FDA for use in anterior capsulotomy, with and without laser phacofragmentation during cataract surgery; and Avedro, Inc., receives CE Mark approval for three new riboflavin formulations for use with it KXL system for corneal collagen cross-linking. In the weekly feature, ophthalmologists discuss some of the best methods and tools for detecting dry eye or ocular surface disease. Watch Video
6/13/2012 | 2,281 views
EyewireTV — Novel AMD Treatment Study Results, Corneal Inlay Phase 3 Study, Presbyopic IOL Surgery
In this week's EyewireTV, results from the first clinical trial of Fovista, a novel anti-PDGF combination agent, show the drug candidate may provide superior efficacy over Lucentis monotherapy for the treatment of wet AMD; and the PresbyLens implantable corneal inlay enters into the final phase of US clinical trials. In the weekly feature, leading ophthalmologists share tips on how to improve discussion with patients preoperatively and offer strategies for optimizing results during presbyopic IOL surgery. Watch Video
6/6/2012 | 1,764 views
EyewireTV — Health Care Costs, New Phaco Simulator, Laser Cataract Surgery Billing
In this week’s EyewireTV, a report from PricewaterhouseCoopers predicts the cost of health care services will rise 7.5% in 2013, more than three times the projected rates for inflation and economic growth; and a new computer-based phacoemulsification simulator developed by the Massachusetts Eye and Ear Infirmary is now available to residents. In the weekly feature, leading ophthalmologists share their thoughts on CMS reimbursement policies and how patients should be billed for laser cataract surgery. Watch Video
5/30/2012 | 1,791 views
EyewireTV — FDA User Fees, New Contact Material, Acne Medication/Eye Infection Link
In this week's EyewireTV, in an effort to make the review process of drugs and medical devices quicker and more efficient, the Senate votes to raise the user fees that industry has to pay to the FDA by more than $2 billion; and research from Tel Aviv University shows that common acne medications such as Accutane or Roaccutane can double the risk of eye infections such as conjunctivitis or sties. In the weekly feature, ophthalmologists talk about the best methods of communicating the benefits and risks of cataract surgery to patients. Watch Video
5/23/2012 | 1,873 views
EyewireTV — Prolensa Study, Executive Management Changes, Premium IOL Adoption
In this week's EyewireTV, findings from the second of two phase 3 studies of Prolensa show the drug candidate to be safe and effective for the treatment of ocular inflammation and pain associated with cataract surgery; and James Mazzo, president of Abbott Medical Optics, announces his plans to retire from AMO at the end of the year. In the weekly feature, ophthalmologists talk about the most effective ways to gauge patients' interest in premium IOLs. Watch Video
5/16/2012 | 1,911 views
Potential Noninvasive Wet AMD Treatments, Fuchs Dystrophy Genetic Link, Technology Obstacles
In this week's EyewireTV, the INTREPID study, which examined Oraya Therapeutics’ radiation therapy for the treatment of wet AMD, has met its primary endpoint; and research confirms that a genetic factor is a strong predictor of an individual’s risk of developing Fuchs dystrophy. In the weekly feature, industry and venture capital executives share their thoughts on overcoming the challenges involved in bringing new technology to the marketplace. Watch Video
5/9/2012 | 3,064 views
EyewireTV — 2-Year CATT Data Reaction, Iluvien UK Approval, LipiFlow Rollout
In this week's EyewireTV, Genentech, the maker of both Avastin and Lucentis, shares its reaction to the 2-year results of the pivotal CATT; and Iluvien intravitreal insert receives approval in the United Kingdom for the treatment of diabetic macular edema. In the weekly feature, retina specialists break down the data from the CATT and share their insight on what the data means for the future treatment of wet AMD. Watch Video
5/2/2012 | 2,803 views
EyewireTV — Two-year CATT Study Results, New OCT Clearance, Cash-Pay Businesses
In this week's EyewireTV, second-year results from the pivotal CATT Study comparing Avastin and Lucentis found that the drugs are equivalent in treating AMD when administered on a monthly or on an as-needed basis; and Optovue Inc. receives FDA 510(k) clearance for the XR version of their flagship RTVue FD-OCT system. In the weekly feature, Robert Grant, formerly of Allergan Medical and Bausch and Lomb Surgical, talks about his new private equity fund, Strathspey Crown LLC, and the potential to create cash-pay businesses that can opt-out of the Medicare/Medicaid system. Watch Video
4/25/2012 | 2,356 views
EyewireTV — iFS Laser Corneal Incisions Clearance, ReLEx Smile US Clinical Trial, Clear Optic IOL Approval
In this week’s EyewireTV, Abbott Medical Optics Inc. receives FDA clearance to create bowshaped or curved arcuate incisions in corneal surgery, including cataract surgery, with the iFS laser; and Carl Zeiss Meditec is granted conditional approval from the FDA to initiate a clinical trial in the United States of the ReLEx smile procedure for the correction of myopia. In the weekly feature, three international ophthalmologists with experience with the ReLEx smile procedure discuss the unique benefits of the technique. Watch Video
4/18/2012 | 2,129 views
EyewireTV — Caffeine/Tear Study, OptiMedica CE Mark Indication, Laser Cataract Adoption
In this week’s EyewireTV, new research shows that caffeine intake can increase the eye’s ability to produce tears; and OptiMedica Corp. receives CE Mark approval for the creation of corneal incisions with the Catalys Precision Laser System. In the weekly feature, early users of femtosecond technology for cataract surgery discuss its potential for widespread adoption. Watch Video
4/11/2012 | 2,304 views
EyewireTV — Ophthalmologist Shortage Survey, Halting AMD Progression, Accutome Sold
In this week's EyewireTV, a large survey shows the number of ophthalmologists is not keeping pace with aging populations and the needs of developing countries; and a study finds that controlling or raising the levels of an inflammatory component in the retinas of patients with dry AMD could prevent its progressing to wet AMD. In the weekly feature, an industry leader, a venture capitalist, and an ophthalmologist share their thoughts on the relationship between venture capital and innovation in today’s ophthalmic market. Watch Video
4/4/2012 | 1,665 views
EyewireTV — FDA Clearance Report, ACOS/Avedro CXL Trial, Improving Surgical Accuracy
In this week’s EyewireTV, a GAO report shows the time it takes the FDA to submit final decisions on 510(k) clearances for medical devices has increased in recent years; and ACOS and Avedro have jointly announced the initiation of a phase 3 clinical trial to examine accelerated corneal collagen cross-linking. In the weekly feature, ophthalmologists share their experiences with the ORA intraoperative wavefront aberrometer and new topography units. Watch Video
3/28/2012 | 4,009 views
EyewireTV — B+L Acquires Ista, B+L CEO Interview, Femto LDV Z Approval
In this week’s EyewireTV, Bausch + Lomb agrees to buy Ista Pharmaceuticals for about $500 million; and Ziemer announces it has received FDA clearance for its recently released Femto LDV Z Models. In the weekly feature, Bausch + Lomb President and CEO Brent Saunders speaks with EyewireTV News Director Stephen Daily about the acquisition and the effect it will have on Bausch + Lomb’s eye care offerings. Watch Video
3/21/2012 | 2,262 views
EyewireTV — Ocriplasmin Commercialization Rights, Spectralis FDA Clearance, Reimbursement Rulings
In this week’s Eyewire TV, Thrombogenics sells the exclusive rights to commercialize ocriplasmin outside the United States to Alcon, and Heidelberg Engineering announces FDA clearance for the Spectralis Anterior Segment Module. In the weekly feature, experts discuss how reimbursement rulings could affect the decisions cataract surgeons make in choosing when and how to adopt new technology. Watch Video
3/14/2012 | 3,304 views
EyewireTV — CXL FDA Application, LensAR Financing, Combined Surgery
In this week’s EyewireTV, Avedro formally submits a new drug application to the FDA for its corneal collagen cross-linking system; and LensAR raises $24 million in private financing to support the commercial launch of its femtosecond laser platform. In the weekly feature, ophthalmologists discuss new microinvasive glaucoma devices that give cataract surgeons the ability to enhance visual outcomes and lower intraocular pressure in one procedure. Watch Video
3/7/2012 | 2,983 views
EyewireTV — CXL Advancements, Phase 3 Dry Eye Treatment Study, LipiFlow MGD Study
In this week’s EyewireTV, Avedro enters into an agreement that could add three major advancements to its existing corneal collagen cross-linking portfolio; and SARcode Bioscience completes patient enrollment in their first phase 3 clinical study of SAR 1118 for the treatment of dry eye disease. In part 2 of EyewireTV’s series on FDA regulation, physicians provide suggestions on what can be done to improve the US regulatory system and make the process of bringing critical technology to market more fluid. Watch Video
2/29/2012 | 2,773 views
EyewireTV — New Femto Laser Platform, Catalys Launch in US, FDA Regulatory Process
In this week's EyewireTV, Ziemer releases a new femtosecond laser platform, Femto LDV Z, designed for a broad variety of applications, including cataract surgery; and a study of Medicare beneficiaries shows rates of post-cataract surgery endophthalmitis in the US in 2003 and 2004 were lower than previous years’ estimates. In the weekly feature, Richard Lindstrom, MD, and R. Doyle Stulting, MD, PhD, speak with EyewireTV during the ACOS-Dulaney Winter Meeting about the FDA regulatory system and its impact on innovation and patient care. Watch Video
2/22/2012 | 2,133 views
EyewireTV — Video Games Vision Study, Diagnostic Code Delay, Patient Comanagement
In this week's EyewireTV, new research reveals that playing video games may improve vision later in life for those with congenital cataracts; and the deadline for physicians to begin using a new and expanded set of diagnostic codes has been delayed. In the weekly feature, physicians talk about the need for increased communication between optometrists and ophthalmolgists, and share tips on how to make comanagement of patients more effective. Watch Video
2/15/2012 | 2,023 views
EyewireTV — Zioptan Glaucoma Drug Approval, Eyetech Acquisition, Anti-Infectives Approval Challenges
In this week's EyewireTV, the FDA approves Zioptan, a solution to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension; and Valeant Pharmaceuticals agrees to acquire Eyetech Inc., a privately-owned ophthalmic biotechnology company specializing in the treatment of retinal diseases. In the weekly feature, ophthalmologists talk about the challenges surrounding the development of new pharmaceutical agents, such as anti-infectives, NSAIDs, and steroids, geared at improving surgical outcomes. Watch Video
2/8/2012 | 2,396 views
EyewireTV — Ocriplasmin Priority Review, ReSure Sealant Trial, CXL Update
In this week's EyewireTV, priority review designation is granted to ThromboGenics’ ocriplasmin for the treatment of symptomatic vitreomacular adhesion, including macular hole; and ReSure Sealant, a proprietary synthetic hydrogel polymer for ophthalmic use over clear corneal incisions, is granted investigational device exemption to conduct a pivotal clinical trial. In the weekly feature, ophthalmologists discuss the benefits of corneal collagen cross-linking and the latest studies involving epi-on and epi-off. Watch Video
2/1/2012 | 3,101 views
EyewireTV — Laser Cataract Surgery Billing, Epilepsy-Cataract Link, FDA NSAID Meeting
In this week's EyewireTV, the two largest ophthalmic medical associations partner to release controversial guidelines they say will assist ophthalmologists in determining their ability to charge Medicare and its beneficiaries for laser cataract surgery; and an upcoming FDA committee meeting will discuss clinical evidence and marketing of nonsteroidal anti-inflammatory drugs for ocular pain following cataract surgery. Watch Video
1/25/2012 | 2,860 views
EyewireTV — Stem Cell Breakthrough, Lucentis China Approval, Dry Eye Treatments
In this week's EyewireTV, human embryonic stem cells for the first time are safely used to treat macular degeneration in two patients, and Novartis receives regulatory approval in China for Lucentis as a treatment for wet AMD. In the weekly feature, cataract surgeons share their thoughts on why there is an increased focus on dry eye disease, and how it is impacting the marketplace for dry eye treatment. Watch Video
1/17/2012 | 2,896 views
EyewireTV — Generic Drug Fees, Ista Offer Increased, Medicare Eye Exam
In this week's EyewireTV, the FDA reaches an agreement that would collect hundreds of millions of dollars in new fees from pharmaceutical companies to help speed up the review of generic drugs, and Valeant Pharmaceuticals raises its takeover offer for Ista Pharmaceuticals. In the weekly feature, leading ophthalmologists discuss what they believe the future holds for the technology behind toric and presbyopia-correcting lenses, and share tips on how to best communicate the benefits of premium lenses with patients. Watch Video
1/11/2012 | 2,752 views
EyewireTV — Aspirin/AMD Link, LASIK Corneal Cross-linking Procedure, Premium IOL Adoption
In this week’s EyewireTV, a large European study links daily aspirin use to an increased risk of age-related macular degeneration, and a proprietary brief corneal cross-linking procedure used in conjunction with LASIK receives CE Mark approval. In the weekly feature, three leading ophthalmologists identify the potential causes of the slow adoption rate of premium IOLs and advise how physicians can better communicate with patients the benefits of the premium implants. Watch Video
1/4/2012 | 2,322 views
EyewireTV — Chief Medical Editors 2012 Preview
Chief medical editors Stephen Slade, MD (Cataract & Refractive Surgery Today), and Steven D. Vold, MD (Glaucoma Today), reflect on 2011 and share their opinions on what they considered the most significant developments in their respective fields. Drs. Slade and Vold also talk about what the hottest trends and new devices will be in ophthalmology in 2012. Watch Video
12/21/2011 | 2,278 views
EyewireTV — OptiMedica Catalys FDA Approval, Takeover Bid for Ista, Online Health Grades
In this week's EyewireTV, OptiMedica Corp. has received FDA 510(k) clearance for its Catalys Precision Laser System for capsulotomy and/or lens fragmentation. Valeant Pharmaceuticals International, Inc., makes a hostile $327 million bid for Ista Pharmaceuticals Inc. In the weekly feature, experts share advice on what steps ophthalmologists should take to optimize their online presence and protect the reputation of their practice. Watch Video
12/14/2011 | 2,209 views
EyewireTV — Cross–linking Designation, Long–Term DME Study, Cataract Surgery Reimbursement
In this week's EyewireTV, the FDA grants orphan drug designation for Avedro’s riboflavin ophthalmic solution, Vibe-X, for use with its corneal cross-linking system to treat corneal ectasia following refractive surgery. In the weekly feature, ophthalmologists talk about how health care legislation may create a more competitive marketplace for the cataract surgeon and how offering premium services could help recoup losses in reimbursement. Watch Video
12/7/2011 | 2,476 views
EyewireTV — Victus CE Mark Approval, Osmolarity System Waiver, Electronic Health Records
In this week's EyewireTV, Bausch + Lomb and Technolas Perfect Vision announce that the Victus femtosecond laser platform has received CE mark approval in Europe; and the TearLab Osmolarity System overcomes a major obstacle that will allow the dry eye detection device to be more widely adopted. In the weekly feature, leading ophthalmologists talk about the discussion they would have with patients regarding charging a premium for laser cataract surgery. Watch Video
11/30/2011 | 2,126 views
EyewireTV — Eylea Approved by FDA, Diabetes/Visual Impairment Study, Health Insurance Premiums
In this week's EyewireTV, Regeneron Vice President of Medical Affairs Beate Stych skypes with EyewireTV about the benefits of Eylea, which recently received FDA approval for the treatment of wet AMD. Also, a new study reveals the percentage of people with diabetes reporting visual impairment dropped substantially over the past 14 years. Watch Video
11/16/2011 | 3,044 views
EyewireTV — Iluvien Setback, Miniature Telescope Implant, Glaucoma Screening
In this week’s EyewireTV, the FDA issues a complete response letter to Alimera stating that it is unable to approve a new drug application for Iluvien for the treatment of diabetic macular edema. In the weekly feature, ophthalmic experts discuss the advantages and disadvantages of European patients having access to technology not yet approved in the United States. Watch Video
11/9/2011 | 2,918 views
EyewireTV — FDA Drug Approvals, Retinal Prothesis, New Medical Devices
In this week's EyewireTV, the FDA releases a statement touting its pace of drug approvals in fiscal year 2011 compared with its European counterparts, and the first commercial implantation of a retinal prosthesis is successfully completed. In the weekly video feature, experts in the ophthalmic industry talk about the regulatory process of medical devices in the United States and whether barriers are causing innovation to move overseas. Watch Video
11/1/2011 | 2,582 views
EyewireTV — Childhood Vision Study, Alzheimer/Cataract Link, Product Labeling
In this week's EyewireTV, a new study reveals that a child’s vision may be affected by the amount of time spent outdoors; and patients with mild Alzheimer disease whose vision improved after cataract surgery also experienced improvements in cognitive ability, mood, sleep patterns, and other behaviors. In the weekly video feature, leading ophthalmologists discuss how increased scrutiny surrounding product labeling can affect pharmaceutical innovation and patient access to the best medicine. Watch Video
10/26/2011 | 2,482 views
EyewireTV — Laser Cataract Finances, Eye Health Survey, ORA Launch
In this week’s EyewireTV News, a new survey released by the Ocular Nutrition Society finds that baby boomers value vision more than any other sense, yet they lack knowledge about ocular health. Also, three leading ophthalmologists sit down with EyewireTV in Orlando to share their thoughts on how physicians can establish a financial model that incorporates femtosecond laser cataract technology into their practice. Watch Video
10/18/2011 | 2,179 views
EyewireTV — WebMD/B+L Partnership, OPKO sale, ACOS Summit
In this week’s EyewireTV News, WebMD Health Corp. and Bausch + Lomb announce an online educational initiative to improve eye care for patients; and OPKO Health, Inc., completes the sale of its ophthalmic instrumentation business to Optos PLC for $17.5 million. Also, ophthalmologists share their experience with EMR and EHR systems, and their advice on the best way to adopt the technology. Watch Video
10/11/2011 | 2,896 views
EyewireTV — Lucentis Price Cut, Topcon/LensAR Deal, Industry Trends
In this week’s EyewireTV News, Novartis drops the price of Lucentis by 30 percent in Switzerland after receiving pressure from the government; and Topcon Europe Medical BV makes an equity investment in LensAR. Also, three industry leaders share their thoughts on what the hottest advancements and biggest challenges to the eye care industry will be over the next 12 to 18 months. Watch Video
10/4/2011 | 2,206 views
EyewireTV — Health Care Reform Mandate, Santen Buys Novagali, LASIK Volumes
In this week’s EyewireTV News, the U.S. Department of Justice has filed a petition asking the Supreme Court to review the 2010 Affordable Care Act, which mandates Americans to purchase health insurance by 2014 or be fined. Also, three experts share their thoughts on how the global financial crisis has affected the laser refractive market, and whether LASIK volumes can bounce back to the levels of years past. Watch Video
9/27/2011 | 3,727 views
EyewireTV — VA Drops Avastin, Stem Cell Trial in Europe, Advancements in Retina
This week’s EyewireTV News, the U.S. Department of Veterans Affairs announces it will stop using bevacizumab to treat wet AMD pending the results of an investigation into its safety. Also, leading vitreoretinal surgeons share their thoughts on the most significant advancements and developments in the retinal arena, including the CATT Study, the latest data on VEGF Trap Eye, microplasmin, and the move from 20-gauge to 23- and 25-gauge microincisional surgery. Watch Video
9/20/2011 | 4,119 views
EyewireTV — Topcon/LensAR Partnership, B+L IOL Launch, Corneal Cross-linking Techniques
John Kanellopoulos MD, Sheraz Daya MD
This week’s EyewireTV News features breaking news from the annual cataract and refractive surgery conference in Vienna, Austria, including Topcon Europe and LensAR announcing their intent to enter into a long-term strategic cooperation to distribute its femtoscond cataract laser surgery system. Also, Sheraz M. Daya, MD, of Queen Victoria Hospital, East Grinstead, United Kingdom, and A. John Kanellopoulos, MD, of Laservision Eye Institute, Athens, Greece, share their thoughts on the most effective corneal collagen cross-linking methods and techniques. Watch Video
9/13/2011 | 3,417 views
EyewireTV—Cross-linking Designation, B+L/Technolas Partnership, Tort Reform
Eric D. Donnenfeld MD, Karl Stonecipher MD, Steven Dell MD
In this week's EyewireTV News, the FDA grants Avedro Inc. orphan drug designation for its riboflavin ophthalmic solution, known as VibeX, for use with its KXL system for corneal cross-linking to treat keratoconus. Also, several top ophthalmologists share their thoughts on the need for medical malpractice reform and the impact it could have on physicians and patients. Watch Video
9/6/2011 | 3,434 views
EyewireTV- Catalys CE Mark Approval; Avastin Eye Infections; Sleep Disorder Study
In this week’s EyewireTV news, Optimedica Corp. announces that it has received CE Mark approval to market its Catalys Precision Laser System for cataract surgery in Europe; and the FDA is alerting health care professionals that repackaged intravitreal injections of Avastin have caused several cases of serious eye infections. Watch Video
8/30/2011 | 2,667 views
EyewireTV—Pediatric Study, Implantable Miniature Telescope, Pattern Scan Laser
In this week’s EyewireTV news, a pediatric study of more than 10,000 children show large variations in the number of children with myopia, hyperopia, and astigmatism; and ophthalmic leaders discuss whether European patients have an advantage in having access to newer technology not yet available in the US. Watch Video
8/23/2011 | 2,629 views
EyewireTV - EYLEA FDA Extension, New PASCAL System, Integrated Medicine
John Doane MD, Mark Kontos MD
In this week’s EyewireTV news feature, John Doane, MD, of Discover Vision Centers in Kansas City, Missouri, and Mark Kontos, MD, a partner of Empire Eye Physicians of Washington and Idaho, discuss the importance of integrated healthcare in today's eye care environment, and how to prepare your practice for the influx of patients that will result from the aging baby boom population. Watch Video
8/16/2011 | 2,207 views
Welcome to the EyewireTV Weekly News Broadcast
Anchorwoman Devyn Gehret provides the most relevant and timely ophthalmic stories of the past week, and Drs. Stephen Slade and Steven Dell sit down with Eyewire News Editor Stephen Daily to discuss the future of femtosecond laser cataract surgery. Watch Video
Advertisement
- General Ophthalmologist
IL (Statewide)
State of the art ophthalmology practice in central Illinois is seeking a general ophthalmologist. Growing multi-subspecialty practice with outstanding patient care and fantastic working environment. Technology progressi...
